Related Experiment Video

Updated: Jun 6, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies

Roberta Palla, Carla Valsecchi, Mariateresa Bajetta

    Thrombosis and Haemostasis
    |November 25, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
    08:50

    Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

    Published on: January 9, 2026

    In Vitro Thrombosis Test for Ventricular Assist Devices
    09:15

    In Vitro Thrombosis Test for Ventricular Assist Devices

    Published on: March 21, 2025

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
    08:01

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

    Published on: February 27, 2026

    Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
    08:50

    Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

    Published on: January 9, 2026

    In Vitro Thrombosis Test for Ventricular Assist Devices
    09:15

    In Vitro Thrombosis Test for Ventricular Assist Devices

    Published on: March 21, 2025

    Related Concept Videos

    Therapeutic Drug Monitoring: Drug Analysis Methods01:26

    Therapeutic Drug Monitoring: Drug Analysis Methods

    Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Development of a portable device for the detection of anti-PEG antibodies in human plasma.

    Scientific reports·2026

    Anti-emicizumab antibodies and their relevance in clinical practice.

    Research and practice in thrombosis and haemostasis·2026

    Implementing an Assay Detecting Anti-Drug Antibody against Emicizumab: Experience from One Center in France.

    Thrombosis and haemostasis·2025

    Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis.

    Blood advances·2024

    Ultrasound evaluation of hemophilic arthropathy: a proposal of definitions in a changing landscape.

    Research and practice in thrombosis and haemostasis·2024

    Evaluation of an automated platelet aggregation method for detection of congenital or acquired platelet function defects.

    Blood transfusion = Trasfusione del sangue·2024

    Chronic Preoperative Corticosteroid Use and Postoperative Venous Thromboembolism Risk: A Systematic Review and Meta-Analysis.

    Thrombosis and haemostasis·2026

    Statin treatment strategy and LDL cholesterol response associate with circulating Amyloid beta 1-40 in a prospective dyslipidemia cohort.

    Thrombosis and haemostasis·2026

    Treatment Approaches and Outcomes of Central Vascular Catheter-related Thrombosis in Neonates: A Canadian Retrospective Cohort Study.

    Thrombosis and haemostasis·2026

    Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit.

    Thrombosis and haemostasis·2026

    Antithrombotic Therapy for Secondary Prevention after Non-Cardioembolic Ischemic Stroke: Current Status, Limitations, and Future Directions.

    Thrombosis and haemostasis·2026

    Clinical Characteristics and Early Outcomes of Acute Pulmonary Embolism Presenting with Syncope.

    Thrombosis and haemostasis·2026

    Downregulation of IFNG-AS1 and UCHL1-AS1 in Peripheral Blood Cells of Multiple Sclerosis Patients: IFNG-AS1 as a Candidate Diagnostic Biomarker.

    International journal of genomics·2026

    LAMA5 pathogenic variant uncovers a novel autoantigen in membranous nephropathy.

    Genes & diseases·2026

    Moxifloxacin-Induced Bullous Acute Generalized Exanthematous Pustulosis (AGEP): A Case Report of a Rare Clinical Presentation.

    Case reports in dermatological medicine·2026

    Anti-biofilm and anti-virulence properties of Ricinus communis and Catharanthus roseus leaves against Pseudomonas aeruginosa PAO1.

    In vitro models·2026

    Multidrug-Resistant Organisms in Combat-Related Injuries: Insights from Iraq, Afghanistan, Ukraine, and Implications for Large-Scale Combat Operations.

    Military medicine·2026

    Timing of surgery for a melioidosis-associated abdominal aortic pseudoaneurysm: a case report.

    Tropical medicine and health·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us